Clinical Trial Update: TNT of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update comparing SCRT plus CAPOX versus SCRT plus CAPOXIRI for locally advanced rectal cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Irinotecan (Irinotecan)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: National Cancer Center Hospital East | Conditions: Locally Advanced Rectal Cancer | Phase 3 | Status: RECRUITING